FDA Eliminates REMS for Lotronex (alosetron hydrochloride)

September 8, 2023 --  Lotronex (alosetron hydrochloride) and approved generics are FDA approved for the treatment of irritable bowel syndrome in women whose predominant bowel symptom is diarrhea.Although safety risks for Lotronex (alosetron...